Allt inom Q2
Nanexa publishes interim report for January – June 2022
The pilot plant inaugurated and GMP certified, patent approved in Europe and product projects approaching clinical phase
Nanexa publishes interim report for January – June 2021
First clinical study started and long-term financing secured